Charlotte’s Web Holdings, Inc., a leading pioneer in hemp-derived CBD wellness, announced its participation as a CBD provider in the newly launched pilot program by the Center for Medicare and Medicaid Innovation. This program represents a historic first, allowing seniors living with cancer to access clinically supported CBD products reimbursed through Medicare and Medicaid. The initiative is designed to create a more personalized and affordable model of care, giving patients and providers much-needed flexibility in exploring therapeutic hemp options. By partnering with the pilot, Charlotte’s Web is helping shape a new standard for senior healthcare access while continuing to support evidence-based use of CBD in clinical settings.
Health Technology Insights: GT Medical Names New GammaTile Center of Excellence
Starting in early 2026, Charlotte’s Web will provide a curated selection of products through a secure online healthcare portal. The platform integrates eCommerce functionality with advanced data security measures to protect both patient and physician information. This initiative builds on the company’s existing medical channel operations and offers the potential for future product expansion tailored to patient needs.
Health Technology Insights: Bioptimus Launches M-Optimus to Transform Biological AI
Bill Morachnick, Chief Executive Officer of Charlotte’s Web, emphasized the significance of the program for underserved seniors facing cancer treatment. He reflected on the company’s origins, explaining that Charlotte’s Web was founded to help Charlotte Figi, whose pioneering experience with medical CBD sparked both research and wider patient access. Morachnick noted that the company remains committed to quality, consistency, and scientific validation, making this program a major milestone in delivering safe, non-intoxicating CBD to patients through established healthcare channels. He also expressed gratitude to the administration, CMMI, and all involved stakeholders for helping bring the initiative to fruition.
Affordability is a key element of the pilot, which addresses a critical gap in senior care. With 67 million Medicare beneficiaries in the United States and nearly 20 percent of seniors using CBD for conditions like pain and arthritis, the program helps reduce out-of-pocket costs while enhancing access. This not only benefits patients directly but also has the potential to lower broader healthcare expenses by supporting preventative and supportive care.
Charlotte’s Web Scientific Advisory Board will oversee the program, ensuring that every aspect adheres to rigorous scientific and ethical standards. The board includes interdisciplinary experts who guide product integrity, education for patients and providers, and long-term innovation strategies. Dr. Marcel Bonn-Miller, Chief Scientific Officer, highlighted that the program integrates clinical insights, patient-reported outcomes, and real-world evidence to ensure both safety and effectiveness of the products offered.
The nonprofit Realm of Caring will support program participants by providing guidance, education, and research coordination. Patients will receive personalized consultations for product selection and dosing, ongoing communication with healthcare providers, and structured outcomes tracking. This comprehensive model ensures that participation goes beyond product access and emphasizes evidence-based, patient-centered care.
Morachnick further explained that this program aligns with Charlotte’s Web’s broader mission to expand medically supported CBD access. He highlighted ongoing research efforts, including Phase 2 FDA clinical trials for hemp-based therapies in autism spectrum disorder through their affiliated company, DeFloria. He emphasized that initiatives like this pilot demonstrate the potential of combining rigorous science with compassionate care to benefit patients who need reliable and affordable CBD healthcare the most.
Health Technology Insights: PADCEV Plus Keytruda Boosts Survival in Bladder Cancer Patients
To participate in our interviews, please write to our HealthTech Media Room at info@intentamplify.com
